In the first half of this year, the biopharmaceutical industry in many places flourished

In recent years, with the continuous improvement of China's medical security level and people's health awareness, the biomedical industry has a huge market space
.
In the first half of this year, after painstaking efforts, many provinces and cities such as Shanghai, Jiangsu, Guangzhou and other provinces and municipalities in the biomedical industry have blossomed and blossomed
.
Shanghai The biopharmaceutical industry is an important pillar of Shanghai's strategic emerging industries.
Shanghai is making every effort to build a world-class biopharmaceutical industry cluster and create a highland for the biopharmaceutical industry
.
In the first half of this year, the scale of Shanghai's biomedical industry exceeded 350 billion yuan, an increase of 22.
8%
.
It is reported that during the "14th Five-Year Plan" period, Shanghai will continue to make efforts in the field of biomedicine from three aspects
.
The first is to speed up research on core technologies, the second is to strengthen the layout in frontier fields, and the third is to accelerate the transformation of innovation results
.
At the same time, it will guide and support the transformation and industrialization of local, national and global biomedical innovation achievements in Shanghai
.
According to Shanghai's goal, by 2025, the scale of the city's biomedical industry will reach twelve hundred billion yuan
.
Jiangsu In recent years, Jiangsu Province has listed the biopharmaceutical industry as one of ten strategic emerging industries and 13 advanced manufacturing clusters, which promoted the rapid and healthy development of the biopharmaceutical industry and achieved outstanding results
.
It is reported that in the first half of this year, the output value of the province's biomedical industry increased by 16.
4% year-on-year
.
In order to promote the high-quality development of the biopharmaceutical industry, Jiangsu Province recently issued the "Several Policies and Measures on Promoting the High-quality Development of the Province’s Biopharmaceutical Industry", from the perspective of industrial development goals, product development, review and approval, manufacturing, and application promotion.
30 policy measures were put forward in 7 areas, including talents, talents and industrial ecology, and formed a "policy package" covering the entire industrial chain to boost the development of the biopharmaceutical industry
.
Guangzhou After years of development, Guangzhou has formed a development situation of “three centers and multiple regions” with R&D in the biological island, pilot trials in the Science City, and manufacturing in the Knowledge City
.
In recent years, Guangzhou has introduced a series of policies and measures, and the scale of the local biomedical industry has achieved steady growth
.
In the first half of 2021, Guangzhou's biomedical health industry achieved an added value of 68.
87 billion yuan, an increase of 12.
0% year-on-year, and the output value of the pharmaceutical manufacturing industry was 23.
995 billion yuan, an increase of 20.
7%
.
There are more than 5,800 various types of biomedical companies in Guangzhou, including 123 pharmaceutical manufacturers, 1,244 medical device manufacturers, and 1,855 cosmetics manufacturers
.
According to the "Guangdong Province's Action Plan for the Development of Biomedicine and Health Strategic Pillar Industry Clusters (2021-2025)" jointly issued by relevant departments in Guangzhou, we will strive to achieve the first-class domestic biomedicine and health industry scale, agglomeration effect, and innovation capability by 2025.
Build a trillion-level industrial cluster and build an industrial highland with international influence
.
Changsha's biomedicine industry is also one of the advantageous industrial clusters cultivated by Changsha City.
After years of development, the city's biomedicine (including gene technology) industrial chain has shown a momentum of rapid, sustained and healthy development
.
It is reported that this year, the city has signed 21 key biomedical projects, 11 new projects, 34 projects under construction, with a planned total investment of 20.
8 billion yuan.
With the continuous implementation of new projects, the high-quality development of the biomedical industry is full of stamina
.
It is understood that the total scale of the Changsha biomedical industry chain in 2020 has exceeded the 100 billion yuan mark, reaching 113.
5 billion yuan
.
According to the "14th Five-Year Plan" of Changsha's biomedical industry, by 2025, the total output value (revenue) of Changsha's biomedicine (including gene technology) industry will reach 250 billion yuan, and there will be about 30 listed companies
.